Bulgaria has suspended its use AstraZeneca vaccine against Covid-19 for women under 60 who are at increased risk of thrombosis, the outgoing Minister of Health announced today.
Bulgaria has given 638,400 people a first dose of the vaccine, almost a third of them the AstraZeneca vaccine, in one of the slowest vaccination campaigns in the EU.
“The AstraZeneca vaccine will not be given to women under the age of 60 with an increased risk of thrombosis and / or a diagnosis of thrombocytopenia,” Konstantin Angelov told reporters.
Angelov pointed out that people who have already been vaccinated with a first dose of AstraZeneca and have not experienced any side effects should be vaccinated with the second dose of the same vaccine.
Those who do not want to take a second dose with AstraZeneca can choose a dose with the Pfizer-BioNTech vaccine almost 84 days after the first dose, he explained.
The Balkan country of 7 million people is expected to receive more than 5.5 million doses of EU-approved vaccine by mid-June, including 3.5 million doses of Pfizer-BioNTech, which will help achieve community immunity by the end of the year. July, Angelov said.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
